Navigation Links
Vasogen Announces Third Quarter 2007 Results
Date:10/9/2007

roceeding as planned and we remain on track with our objective of

launching Celacade in Europe before the end of the year.

- Today we announced that a recently published book,

"Immune Dysfunction and Immunotherapy in Heart Disease," discusses

the Celacade System for the treatment of heart failure. The chapter

entitled "Anti-inflammatory therapy in heart failure," describes how

the growing understanding of the role inflammation in heart failure

has led to new treatment modalities and describes the potential of

Celacade to target this underlying pathology. The authors of the

chapter describe the mechanism of action of Celacade and review the

results of the ACCLAIM trial. Regarding the results of the trial, the

authors state: "These findings are consistent with the role that

chronic inflammation plays in the development and progression of HF

and are particularly impressive in the large subgroup of

NYHA Class III or IV patients who had not experienced a prior heart

attack and in all NYHA class II patients. These results provide a

strong basis for targeting Celacade's novel anti-inflammatory

mechanism in this large and well-defined patient population."

As previously announced, a conference call will be conducted on October 9, 2007, at 4:30 p.m. Eastern time. The conference call may be accessed by calling 416-641-6124 or 1-866-300-4047 ten minutes prior to the call. An audio web cast of the event will also be available at http://www.vasogen.com. A re-broadcast of the conference call may be accessed by calling 416-695-5800 or 1-800-408-3053, PIN code 3238234 followed by the number sign, and will also be available at http://www.vasogen.com.

About Vasogen:

Vasogen is a biotechnology company
'/>"/>

SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 Nashville Fertility Center announced that ... for the American Society for Reproductive Medicine (ASRM), a ... in reproductive medicine. In his new role as ... executive board and will have a voice in furthering ... actively supported ASRM since 1984 when he joined while ...
(Date:12/24/2014)... CA (PRWEB) December 23, 2014 Pipette.com ... where their Twitter followers can submit their #HolidayInTheLab pictures ... and their lab mates. , For those struggling to ... mates, the Pipette.com Holiday in the Lab Contest provides ... Pipette.com Twitter followers to send pictures of their ...
(Date:12/24/2014)... Texas , Dec. 23, 2014 ... company focused on gynecologic disease, announced today that ... Schuler , Birchview Fund LLC and several Vermillion ... of unregistered shares of Vermillion,s common stock and ... stock in a private placement.  ...
(Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
... Editors Note: The Wisconsin Technology Council has ... industry. The 24-page publication highlights the states research ... key contacts and the I-Q Corridor that joins ... Wisconsin Technology Network has arranged to post excerpts ...
... , a supplier of automotive systems and facility management ... its processes. Jim Hayes, the companys delivery systems manager, ... , a Florida-based company that wrote its Analytic Freedom ... ,The software automatically categorizes words and phrases and looks ...
... / CMMI Evolution, not revolution , ,Your ... annual PMI membership dues. Youve been to training, regularly ... your pillow (osmosis). The methodology on your desk is ... Ill bet you could recite the cost control section ...
Cached Biology Technology:Life Sciences: Wisconsin - The Smart Choice Part Two 2Life Sciences: Wisconsin - The Smart Choice Part Two 3Life Sciences: Wisconsin - The Smart Choice Part Two 4Life Sciences: Wisconsin - The Smart Choice Part Two 5Life Sciences: Wisconsin - The Smart Choice Part Two 6Life Sciences: Wisconsin - The Smart Choice Part Two 7Part 5 Project Performance Get on the path to continuous improvement 2Part 5 Project Performance Get on the path to continuous improvement 3Part 5 Project Performance Get on the path to continuous improvement 4
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ... is the ultimate driver in long-term mass consumer adoption ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... PAUL (August 1, 2011) Using state-of-the-art, 7 Tesla magnetic ... researchers may have uncovered a better approach to diagnosing ... was able to cure eight patients of all epileptic ... seizures or convulsions, impacts about one percent of the ...
... 2011, Shenzhen, China and San Diego, CA BGI, ... Inc., a privately held biotechnology company that utilizes a ... discovery and design of new products and processes for ... study on the genomic sequence of the Chinese hamster ...
... A new source of very cold electrons will improve the ... to a trillionth of a second. The study published ... researchers from the ARC Centre of Excellence for Coherent X-ray ... Professor Robert Scholten from the University,s School of Physics ...
Cached Biology News:U of M researchers use improved imaging technique; discover a better approach to diagnosing epilepsy 2Genome of CHO-K1 provides new insights into optimization of biopharmaceutical protein production 2Genome of CHO-K1 provides new insights into optimization of biopharmaceutical protein production 3Cold electrons to aid better design of drugs and materials 2
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... Rabbit polyclonal to ErbB 2 - ... for all tested applications). ... AENPEYLGLDVPV conjugated to KLH, corresponding to ... Human c-ErbB2 Entrez ...
Anti human PPAR gamma2 mouse monoclonal antibody...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
Biology Products: